SurgePays (SURG) 10-Q Reveals Going Concern Doubt, Cash Crisis

SurgePays SSURG filed its Q2 2026 10-Q on August 19, 2026, and the document painted a sharply darker picture than the preliminary release six days earlier. The filing disclosed just $1.95M in cash, a $21.3M working capital deficit, and a $20.75M stockholders' deficit. Management explicitly stated there is insufficient cash to meet obligations over the next 12 months, triggering a going concern doubt. SURG fell 24-30% in after-hours and pre-market trading on August 20, deepening a session that had already seen the stock slip roughly 8% to around $0.25 on August 19. For more filing reactions and market signals, visit the Market News hub.

What happened

The 10-Q arrived after SurgePays issued a delay notification, a red flag for microcap disclosures. The filing showed the company ended the first six months of 2026 with only $1.95M in cash, down from $2.42M at the close of Q1 2026 (ended April 14, 2026). The six-month operational cash burn totaled $7.18M.

Total liabilities stood at approximately $33.37M against $9.50M in assets as of Q1 2026, producing a stockholders' equity deficit that deepened to $20.75M by mid-year. The company carried roughly $13M in convertible notes and $15.51M in total debt as of Q1 2026.

On August 14, SurgePays had released preliminary Q2 results reporting $16.2M in revenue, up 40.7% year-over-year, and GAAP net income of $1.29M. The 10-Q confirmed that the bottom-line profit rested almost entirely on an $8.51M one-time, non-cash gain related to an AT&T transaction. Stripping that item, the company ran a material operating loss during the quarter.

Management acknowledged in the filing that existing cash and projected cash flows are not sufficient to fund operations for the next 12 months, raising a formal going concern doubt under accounting standards.

Why it matters

The disconnect between the August 14 headline and the 10-Q details is significant for research workflows. Revenue growth and a reported profit can mask structural weakness when a single non-cash item drives the bottom line. The $7.18M operational cash burn over six months against $1.95M in remaining cash creates a stark runway problem, especially with $13M in convertible notes on the books.

A going concern qualification does not automatically trigger bankruptcy, but it raises the probability of dilutive financing, asset sales, or restructuring negotiations. For a microcap with a history of reporting delays, that uncertainty tends to compound price pressure quickly. The stock has already shed more than 90% of its value over the trailing 12 months, declining from roughly $1.14 in January 2026 to under $0.20 by August 2026.

Short interest also adds a layer of pressure. As of late July 2026, short interest sat at approximately 1.85M shares against a 16M share float, with days-to-cover near 2.2. Accelerated covering on the filing news could amplify the intraday move.

SURG Price Reaction After Q2 10-Q Filing

September 2023 to August 2026 (monthly close)

Open SURG →

Powered by

What to watch next

Investors tracking SURG should monitor three concrete follow-ups. First, any 8-K filing disclosing management plans to address the going concern, such as a financing round, asset sale, or debt restructuring. Second, the Q2 full income statement and cash flow statement to quantify exactly how much of the $1.29M net income was the AT&T gain versus operational performance. Third, volume and short interest data on August 20 to gauge whether the after-hours decline continues into the regular session, and whether short covering is amplifying the move. Finally, watch for any Nasdaq compliance notices, as sub-$1 share prices and equity deficits can trigger delisting review for Nasdaq-listed companies.